1-7 of 7
Claes Malm, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Disease Relapse after Tyrosine Kinase Inhibitor Treatment Discontinuation in CML Is Related Both to Low Number and Impaired Function of NK-Cells

Mette Matilda Ilander, MSc, Ulla Olsson-Strömberg, MD PhD, Hanna Lähteenmäki, MSc, Kasanen Tiina, Perttu Koskenvesa, MD, Stina Söderlund, MD, Martin Höglund, MDPhD, Berit Markevärn, MD, Anders Själander, MD PhD, Kourosh Lotfi, MDPhD, Claes Malm, MD, Anna Lubking, MD, Marja Ekblom, MD PhD, Elena Holm, MD, Mats Björeman, MD, Sören Lehmann, MD PhD, Leif Stenke, MD PhD, Lotta Ohm, MD PhD, Waleed Majeed, MD, Markus Pfirrmann, PhD, Martin C Muller, MD, Joelle Guilhot, PhD, Hans Ehrencrona, MD PhD, Henrik Hjorth-Hansen, MD PhD, Susanne Saussele, Francois-Xavier Mahon, MD PhD, Kimmo Porkka, MD PhD, Johan Richter, MD PhD, Satu Mustjoki, MDPhD
Journal: Blood
Blood (2014) 124 (21): 812.
https://doi.org/10.1182/blood.V124.21.812.812
Published: 2014
Journal Articles

Dasatinib Treatment Induces Fast and Deep Responses In Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients In Chronic Phase: Clinical Results From a Randomized Phase 2 Study (NordCML006)

Henrik Hjorth-Hansen, MD, PhD, Johan Richter, MD, PhD, Leif Stenke, MD, PhD, Hans Ehrencrona, MD, PhD, Bjørn Tore Gjertsen, MD, PhD, Tobias Gedde-Dahl, III, MD, PhD, Perttu Koskenvesa, MD, Claes Malm, MD, Waleed Majeed, MD, Lotta Ohm, MD PhD, Martin Hoglund, MD PhD, Ulla Olsson-Strömberg, MD, PhD, Stina Söderlund, MD, Merja Suominen, MD, Kari Remes, MD PhD, Berit Markevärn, MD, Bengt Simonsson, MD PhD, Kimmo Porkka, MD, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4032.
https://doi.org/10.1182/blood.V122.21.4032.4032
Published: 2013
Journal Articles

Disease Relapse After TKI Discontinuation In CML Is Related Both To Low Number and Impaired Function Of NK-Cells:Data From Euro-SKI

Mette Matilda Ilander, MSc, Ulla Olsson-Strömberg, MD, PhD, Hanna Lähteenmäki, MSc, Tiina Kasanen, Perttu Koskenvesa, MD, Stina Söderlund, MD, Martin Hoglund, MD, PhD, Berit Markevärn, MD, Anders Själander, MD, PhD, Kourosh Lofti, MD, PhD, Claes Malm, MD, Anna Lubking, MD, Marja Ekblom, MD, PhD, Elena Holm, MD, Mats Björeman, MD, Sören Lehmann, MD, PhD, Leif Stenke, MD, PhD, Lotta Ohm, MD, Henrik Hjorth-Hansen, MD, PhD, Susanne Saussele, MD, Francois-Xavier Mahon, MD, PhD, Kimmo Porkka, MD, PhD, Johan Richter, MD, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 379.
https://doi.org/10.1182/blood.V122.21.379.379
Published: 2013
Journal Articles

Impact of Chronic Graft-Versus-Host disease (GVHD) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) As Treatment for Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of the EBMT

Frederic Baron, MD, PhD, Myriam Labopin, MD, MS, Dietger Niederwieser, MD, noel-Jean Milpied, MD, Jan J Cornelissen, MD PhD, Claes Malm, MD, Lars Vindelov, MD, Didier Blaise, MD, Jeroen JWM Janssen, MD, Eefke J Petersen, MD PhD, Gerard Socie, Vanderson Rocha, MD, PhD, Arnon Nagler, Mohamad Mohty
Journal: Blood
Blood (2011) 118 (21): 321.
https://doi.org/10.1182/blood.V118.21.321.321
Published: 2011
Journal Articles

Favorable Therapeutic Responses in Newly Diagnosed CML-CP Patients Induced by Dasatinib Are Reflected At the CD34+CD38+ Progenitor Cell but Not At the CD34+CD38− Stem Cell Level: Results From Randomized NordCML006 Study

Satu Mustjoki, MD, PhD, Johan Richter, MD, PhD, Gisela Barbany, MD, PhD, Hans Ehrencrona, MD, PhD, Ingunn Dybedal, MD, PhD, Thoas Fioretos, MD, PhD, Tobias Gedde-Dahl, MD, PhD, Bjorn Gjertsen, MD, PhD, Randi Hovland, PhD, Sari E Jalkanen, MSc, Dag Josefsen, MD, PhD, Perttu Koskenvesa, MD, Carin Lassen, Msc, Kirsi Latvala, Waleed Majeed, MD, Claes Malm, MD, Berit Markevärn, MD, Ali Mosfegh, PhD, Lotta Ohm, MD, Tor Olofsson, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Katrin Rapakko, PhD, Kari Remes, MD PhD, Jesper Stentoft, MD, PhD, Leif Stenke, MD, PhD, Merja Suominen, MD, Sara Thunberg, PhD, Ole Weiss Bjerrum, MD, PhD, Bengt Simonsson, MD, PhD, Kimmo Porkka, MD, PhD, Henrik Hjorth-Hansen, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 784.
https://doi.org/10.1182/blood.V118.21.784.784
Published: 2011
Journal Articles

The Proportion of Ph+ CD34 + CD38 neg Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and Correlates with High Sokal Risk, High Leukocyte Count, Low Hemoglobin Concentration, Splenomegaly and Increased Hematological Toxicity During Initial TKI-Therapy. Data From a Randomized Phase II NordCML006 Study

Satu Mustjoki, MD, PhD, Johan Richter, MD, PhD, Gisela Barbany, MD, PhD, Ingunn Dybedal, MD, PhD, Thoas Fioretos, MD, PhD, Tobias Gedde-Dahl, MD, PhD, Bjorn T. Gjertsen, MD, PhD, Randi Hovland, PhD, Sari Jalkanen, Msc, Dag Josefsen, MD, PhD, Perttu Koskenvesa, MD, Carin Lassen, Kirsi Latvala, Waleed Majeed, MD, Claes Malm, MD, Berit Markevärn, MD, Ali Moshfegh, PhD, Lotta Ohm, MD, Tor Olofsson, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Katrin Rapakko, PhD, Kari Remes, MD, PhD, Jesper Stentoft, MD, PhD, Leif Stenke, MD, PhD, Merja Suominen, MD, Sara Thunberg, MD, PhD, Ole Weiss Bjerrum, MD, PhD, Bengt Simonsson, MD, PhD, Kimmo Porkka, MD, PhD, Henrik Hjorth-Hansen, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 667.
https://doi.org/10.1182/blood.V116.21.667.667
Published: 2010
Journal Articles

A Randomized Phase II Study Comparing Imatinib and the Combination of Imatinib and Pegylated Interferon Alpha-2b in Newly Diagnosed Non-High Risk Chronic Myeloid Leukemia (CML) Patients in Complete Hematological Remission After Imatinib Induction Therapy.

Bengt Simonsson, MD, Tobias Gedde-Dahl, MD, Berit Markevärn, MD, Kari Remes, MD, Jesper Stentoft, MD, Anders Almqvist, MD, Mats Björeman, MD, Max Flogegård, MD, Heikki Hallman, MD, Perttu Koskenvesa, MD, Anders Lindblom, MD, Claes Malm, MD, Satu Mustjoki, MD, Kristina Myhr-Eriksson, MD, Anu Räsänen, MD, Marjatta Sinisalo, MD, Risto Sippola, MD, Anders Själander, MD, Ulla Strömberg, MD, Ole Weiss Bjerrum, MD, Hans Ehrencrona, MD, Franz Gruber, MD, Veli Kairisto, MD, Karin RN Olsson, Arnon Nagler, MD, Johan Lanng Nielsen, MD, Henrik Hjorth-Hansen, MD, Kimmo Porkka, MD, for the Nordic CML Study Group (NCMLSG)
Journal: Blood
Blood (2009) 114 (22): 3280.
https://doi.org/10.1182/blood.V114.22.3280.3280
Published: 2009